Answers - Stockpickr! Your Source for Stock Ideas

Q: Dylan Radigan to abc??
http://www.ritholtz.com/blog/2009/03/cnbcs-dylan-ratigan-to-abc/
Asked by steiny* near I-25 and I-70 - 1 months ago - 6 answers - 13219 views
Bookmark this User - Bookmark this question - Report Abuse
A: My husband and I both enjoyed watching Dylan Radigan. His knowledge, familiarity with the
subjects, as well as insight and perspective, always held our interest.

Most of all his gentlemanly manner in all his dealings with people, whether as a host or
as a guest, added to our interest and enjoyment as we watched the show.

We'll miss his humor and input. Hopefully he'll be on our local tv channels. more
Post your own answer
Q: i bought bac and i dont know weather to hold or sell. i have lost alot of money
in this stock. should ii hold or walk away.
Asked by jimmy07 - 1 months ago - 64 answers - 10683 views
Bookmark this User - Bookmark this question - Report Abuse
A: sell on this large volume
(I mean 10225 views for this question) more
Post your own answer
Q: What happened to Dillon Ratigan?
Asked by beachbum242 - 1 months ago - 15 answers - 9260 views
Bookmark this User - Bookmark this question - Report Abuse
A: Who cares? He didn't get off the soap box.
Every show became a forum for his opinions. The show is to help traders make 'fast money
not to hear his opinions. I thing what he said was correct but it was the wrong venue. He
should go on Fox and join the whinners there. more
Post your own answer
Q: J.M. Smucker's Valuation Final Version-

http://www.sendspace.com/file/ckv1dd

15 Page Report, estimated price target, quant screen, and reported information
Asked by kabirm - 1 months ago - 1 answers - 8266 views
Bookmark this User - Bookmark this question - Report Abuse
A: nice writeup K more
Post your own answer
Q: What does everyone / anyone think about Cell Therapeutics, Inc.? (Stock
Symbol: CTIC)
Asked by AR333 - 1 months ago - 5 answers - 7673 views
Bookmark this User - Bookmark this question - Report Abuse
A: I agree with previous comments. I am a medical oncologist and knows Pixantrone very well.
I owns 500K shares at 5 cents and it has increased by 8 times, SO FAR! more
Post your own answer
Q: non-mandatory reorganization or tender offer what does this mean?
Asked by louis fernandez - 1 months ago - 2 answers - 7298 views
Bookmark this User - Bookmark this question - Report Abuse
A: here's another definition

http://www.investorwords.com/5765/reorganization.html

you should bookmark these sites, incase your looking for other definitions. more
Post your own answer
Q: Stockpickrs,
I have a wash sale question. How similar does the company have to be to count?
For example, if you sold POT for a loss and bought MOS a week or so later I'm
guessing that you can't write off the loss. But what if you bought MON? In
other words, how similar do the companies have to be?
Asked by bk10 - 1 months ago - 4 answers - 6053 views
Bookmark this User - Bookmark this question - Report Abuse
A: Wash sale rule would apply strictly to stock of same company. Like kind or similar
'anything' would not apply nor be considered. more
Post your own answer
Q: I sold my UNG holdings because of Cramer being bearish on it and saying it could
have another leg down.

I stay away from stocks that get negative notes. Like FSLR getting a downgrade
and price target to 120. I sold out of it.

SII getting a price target cut to 24$. I sold out of that.

I didnt sell for a loss, but didnt sell for gains. After last years sell off, I
dont have any tolerance for stocks that get downgraded or have people like
cramer that say it has another leg down.

Thoughts?
Asked by blurpkin - 1 months ago - 17 answers - 5874 views
Bookmark this User - Bookmark this question - Report Abuse
A: Agree with you on FSLR for a couple reasons. Fundamentally things are not going their way:
price / productivity issues against the Poly Silicon competition - especially China
(Yingli, et al.) - This was basically the reason they were downgraded. Also the technicals
look poor for FSLR. After their end of April gap up into the clouds on earnings and future
revenue promise, they fell back a bit then got to that mid-May double top. This has given
way to falling prices and fading volume (lower than avg. vol even on the only 2 up days in
the last 10, so we can't even hold on to the hope that we are seeing only light volume
pullbacks).

Only a matter of time before we see headlines like : "FSLR - the stock that fell to
earth."

You got out while the getting was good. Or at least not as bad as it would have been. more
Post your own answer
Q: I OWN SOME SHARES OF BAC AT 7.33 PER SHARE. SHOULD I HOLD OR SELL.
Asked by ANGELO 11 - 1 months ago - 15 answers - 5287 views
Bookmark this User - Bookmark this question - Report Abuse
A: Take profits now. more
Post your own answer
Q: What price range for DNDN prior to the 28th and do you sell before or after the
28th.
Asked by GLKUHN - 1 months ago - 1 answers - 5190 views
Bookmark this User - Bookmark this question - Report Abuse
A: On Apr. 28, Dendreon (DNDN) presents more details of the results of their experimental
prostate cancer drug that they claim prolongs the life of men with advanced prostate
cancer by stimulating an immune response to fight malignant cells. Our conservative stock
model recommends a ‘Sell’ with a rating of D- as this research company has virtually
no sales to backup the current valuation. In many cases, the over-reaction to the upside
loses steam when the reality of how long it takes to monetize study results is made clear.
This favors locking in gains prior to the 28th. more
Post your own answer
- Previous
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- ...
- 1653
- Next

Didn't see the answer you were looking for?
Post a new question for Stockpickr’s Community.

Please be advised that the answers provided by any member of TheStreet.com or Stockpickr community represents his or her own opinions, and that none of TheStreet.com, Stockpickr or James Cramer will assess, verify or guarantee the suitability or profitability of any particular investment. You should not rely solely upon information provided on this page for purposes of transacting securities or other investments. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment.
Please report any violations of the TOS to StockpickrSupport@thestreet.com